H19 Overexpression in Breast Adenocarcinoma Stromal Cells Is Associated with Tumor Values and Steroid Receptor Status but Independent of p53 and Ki-67 Expression
- 1 November 1998
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 153 (5) , 1597-1607
- https://doi.org/10.1016/s0002-9440(10)65748-3
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Role of theH19 gene in Syrian hamster embryo cell tumorigenicityMolecular Carcinogenesis, 1997
- The expression of the imprinted genes H19 and IGF-2 in choriocarcinoma cell lines. Is H19 a tumor suppressor gene?Oncogene, 1997
- Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptorSurgery, 1996
- MODULATIONS OF THE H19 GENE EXPRESSION IN NORMAL OR MALIGNANT MAMMARY EPITHELIAL CELLSBiology of the Cell, 1996
- Epigenetic lesions at the H19 locus in Wilms' tumour patientsNature Genetics, 1994
- Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumourNature Genetics, 1994
- Tumour-suppressor activity of H19 RNANature, 1993
- Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumourNature, 1993
- Monoallelic expression of the human H19 geneNature Genetics, 1992
- The human ASM (Adult Skeletal Muscle) gene Expression and chromosomal assignment to 11p15Biochemical and Biophysical Research Communications, 1991